IOL Chemicals and Pharmaceuticals · NSE: IOLCP · BSE: 524164
Q1 FY26 results · Apr–Jun 2025
IOL Chemicals and Pharmaceuticals reported revenue from operations of ₹551.69 crore (up 9.8% from Q1 FY25) and net profit of ₹33.93 crore (up 13.2% from Q1 FY25) for Q1 FY26 (Apr–Jun 2025), on a consolidated basis.
| Item | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 551.69 | 502.38 | +9.8% | 527.78 | +4.5% |
| Other income | 7.37 | 7.38 | −0.1% | 4.53 | +62.7% |
| Total income | 559.06 | 509.76 | +9.7% | 532.31 | +5.0% |
| Profit before tax | 45.51 | 39.52 | +15.2% | 44.70 | +1.8% |
| Net profit for the period | 33.93 | 29.97 | +13.2% | 31.42 | +8.0% |
| EPS, basic (₹) | 1.16 | 5.11 | not comparable | 1.07 | +8.4% |
| Net margin (%) | 6.2 | 6.0 | 6.0 |
| Item | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 551.69 | 502.38 | +9.8% | 527.78 | +4.5% |
| Other income | 7.37 | 7.38 | −0.1% | 4.52 | +63.1% |
| Total income | 559.06 | 509.76 | +9.7% | 532.30 | +5.0% |
| Profit before tax | 45.54 | 39.23 | +16.1% | 44.90 | +1.4% |
| Net profit for the period | 33.96 | 29.68 | +14.4% | 31.62 | +7.4% |
| EPS, basic (₹) | 1.16 | 5.06 | not comparable | 1.08 | +7.4% |
| Net margin (%) | 6.2 | 5.9 | 6.0 |
Consolidated
- Filed with BSE
- 07 Aug 2025, 15:23 IST
- Board meeting
- 07 Aug 2025
- Period
- 01 Apr 2025 to 30 Jun 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 07 Aug 2025, 15:23 IST
- Board meeting
- 07 Aug 2025
- Period
- 01 Apr 2025 to 30 Jun 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE